These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6093296)

  • 1. Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease.
    Lönnqvist B; Ringdén O; Wahren B; Gahrton G; Lundgren G
    Transplantation; 1984 Nov; 38(5):465-8. PubMed ID: 6093296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of factors predisposing to chronic graft-versus-host disease.
    Ringdén O; Paulin T; Lönnqvist B; Nilsson B
    Exp Hematol; 1985 Nov; 13(10):1062-7. PubMed ID: 2996920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection after marrow transplantation for aplastic anemia.
    Ljungman P; Niederwieser D; Pepe MS; Longton G; Storb R; Meyers JD
    Bone Marrow Transplant; 1990 Nov; 6(5):295-300. PubMed ID: 1963336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
    Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection in leucocytes after bone marrow transplantation demonstrated by mRNA in situ hybridization.
    Link H; Battmer K; Stumme C
    Br J Haematol; 1993 Nov; 85(3):573-7. PubMed ID: 8136281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.
    Würsch AM; Gratama JW; Middeldorp JM; Nissen C; Gratwohl A; Speck B; Jansen J; D'Amaro J; The TH; De Gast GC
    Clin Exp Immunol; 1985 Nov; 62(2):278-87. PubMed ID: 3002684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Jacobsen N; Andersen HK; Skinhøj P; Ryder LP; Platz P; Jerne D; Faber V
    Scand J Haematol; 1986 May; 36(5):499-506. PubMed ID: 3016881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
    Storb R; Deeg HJ; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Hansen J
    Br J Haematol; 1989 Aug; 72(4):567-72. PubMed ID: 2673331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies.
    Siegal D; Xu W; Sutherland R; Kamel-Reid S; Kuruvilla J; Lipton JH; Minden M; Messner H; Gupta V
    Bone Marrow Transplant; 2008 Jul; 42(1):51-6. PubMed ID: 18372907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients.
    Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M
    Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia.
    Miyamura K; Kojima S; Takeyama K; Matsushita T; Fukuda M; Horibe K; Minami S; Morishima Y; Matsuyama K; Kodera Y
    Bone Marrow Transplant; 1988 Sep; 3(5):457-61. PubMed ID: 3056553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus.
    Larsson K; Aschan J; Remberger M; Ringdén O; Winiarski J; Ljungman P
    Transplantation; 2004 Feb; 77(4):526-31. PubMed ID: 15084929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
    Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
    Transplantation; 1998 Sep; 66(5):620-5. PubMed ID: 9753343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faster immunological recovery after bone marrow transplantation in patients without cytomegalovirus infection.
    Paulin T; Ringdén O; Lönnqvist B
    Transplantation; 1985 Apr; 39(4):377-84. PubMed ID: 2984810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.